Increasing measles vaccination coverage with incentive-based SQ-LNS supplementation in children aged 6 to 23 months
Malnutrition and infectious diseases form a vicious circle and represent a double threat for children in low- and middle-income countries. Small-quantity lipid-based nutritional supplements (SQ-LNS) are a category of ready-to-use, nutrient-rich and fortified food supplements designed to prevent malnutrition and improve child survival, growth and development. Supplementing children aged between 6 and 23 months with SQ-LNS in food-insecure areas with low vaccination coverage is also a promising way of encouraging vaccination and other health services.
The NutriVax-Measles research project, entitled Increasing measles vaccination coverage through supplementation with SQ-LNS incentive in children aged 6-23 months, is a pragmatic randomised parallel cluster controlled trial conducted in Yobe State, northern Nigeria.
The main objective is to estimate the effectiveness of a mass SQ-LNS supplementation programme added to the routine vaccination programme compared with the routine vaccination programme alone in terms of measles vaccination coverage, after 12 months of implementation of the programme, in children aged 12 to 23 months as part of the end-of-study cross-sectional household survey.
Cécile CAZES
cecile.cazes@coral.alima.ngo
Discover our activities
in research and teaching
of Bordeaux's university sites.
. University of Bordeaux
. Institute of Public Health, Epidemiology and Development (Isped)
. Bordeaux Population Health Research Center (BPH)
. Bordeaux School of Economics (BSE)
. Sciences Po Bordeaux
Click on the names of the countries where we operate below the map!
